您的位置:梦戴维官网 > 学术论文 >
中高度近视青少年配戴角膜塑形镜联合框架眼镜的疗效和安全性

目前,我国药监局批准角膜塑形镜近视矫正度数大部分在4、500度,最高只能针对600度以下的近视人群,但是一些近视度数超过600度以上的孩子怎么办? 由广州军区武汉总医院眼科,常枫,沈政伟,陈云辉,魏润菁,李梅,章晨爽,叶银,周和政 等人发表在中华眼视光学与视觉科学杂志的论文或许可以帮助您解决次问题。

论文摘要

目的 观察夜晚配戴角膜塑形镜联合白天配戴框架眼镜矫治中高度青少年近视的临床疗效和安全性。

方法 前瞻性观察研究。收集中高度(-4.00 D以上)青少年近视患者38例(75眼),年龄11~19岁,平均等效球镜度(SE)(-6.76±1.45)D。夜晚配戴角膜塑形镜1个月后,白天采用框架眼镜矫正残余近视度。采用重复测量的方差分析比较戴镜前和戴镜后各参数变化。

结果 裸眼视力(UCVA):配戴角膜塑形镜前和戴镜后1 d、1周、1个月、1年分别为3.93±0.27、4.53±0.21、4.85±0.19、4.90±0.11、4.94±0.13;配戴角膜塑形镜前和戴镜1年后散瞳验光的SE差异无统计学意义;IOLMaster测量戴镜前和戴镜1年后眼轴长度分别为(26.88±1.03)mm、(26.91±1.10)mm,差异无统计学意义。随访期间未发生严重并发症。

结论 夜晚配戴角膜塑形镜联合白天配戴框架眼镜矫正残余近视度数的方法可以有效提高中高度青少年近视患者UCVA,短期内控制近视度数加深和眼轴增长,无明显的并发症发生。

论文详细请参考:中华眼视光学与视觉科学杂志 2015, Vol. 17 Issue (6): 360-363页,论文摘要链接:http://www.cjoovs.com/CN/Y2015/V17/I6/360,其实早在2013年美国就有相关的论文研究了,感兴趣的朋友可以参考:高度近视如何通过角膜塑形术控制近视发展

参考文献:

[1] Pan CW, Ramamurthy D, Saw SM. Worldwide prevalence and risk factors for myopia[J]. Ophthalmic Physiol Opt,2012,32(1):3-16.

[2] Sawada A, Tomidokoro A, Araie M, et al. Refractive errors in an elderly Japanese population: The Tajimi Study[J]. Ophthalmology,2008,115(2):363-370.

[3] Wong TY, Foster PJ, Hee J, et al. Prevalence and risk factors for refractive errors in adult Chinese in Singapore[J]. Invest Ophthalmol Vis Sci,2000,41(9):2486-2494.

[4] Pan CW, Wong TY, Lavanya R, et al. Prevalence and risk factors for refractive errors in Indians: The Singapore Indian Eye Study (SINDI)[J]. Invest Ophthalmol Vis Sci,2011,52(6):3166-3173.

[5] Liu HH, Xu L, Wang YX, et al. Prevalence and progression of myopia retinopathy in Chinese adults: The Beijing Eye Study[J]. Ophthalmology,2010,117(9):1763-1768.

[6] He M, Zheng Y, Xiang F. Prevalence of myopia in urban and rural children in mainland China[J]. Optom Vis Sci,2009,86(1):40-44.

[7] Zhang M, Li L, Chen L, et al. Population density and refractive error among Chinese children[J]. Invest Ophthalmol Vis Sci,2010,51(10):4969-4976.

[8] 瞿小妹,储仁远. 角膜塑形术临床疗效及其相关因素[J]. 眼视光学杂志,2004,6(1):6-9.

[9] 储仁远,谢培英. 现代角膜塑形学[M]. 北京:北京大学医学出版社,2006:138-164.

[10] Kakita T, Hiraoka T, Oshika T. Influence of overnight orthokeratology on axial length elongation in childhood myopia[J]. Invest Ophthalmol Vis Sci,2011,52(5):2170-2174.

[11] Walline JJ, Jones LA, Sinnott LT. Corneal reshaping and myopia progression[J]. Br J Ophthalmol,2009,93(9):1181-1185.

[12] 戴祖优,曾骏文,钟兴武,等. 角膜塑形术控制近视发展的临床观察[J]. 眼视光学杂志,2008,10(4):288-290,294.

[13] 谢培英,迟蕙. 实用角膜塑形学[M]. 北京:人民卫生出版社,2012:62.

[14] Charm Jessie, Cho Pauline. High myopia-partial reduction orthokeratology (HM-PRO): Study design[J]. Contact Lens Anter,2013,36(4):164-170.

[15] Lin HJ, Wan L, Tsai FJ, et al. Overnight orthokeratology is comparable with atropine in controlling myopia[J]. BMC Ophthalmol,2014,14:40-48.

[16] Pan CW, Ramamurthy D, Saw SM. Worldwide prevalence and risk factors for myopia[J]. Ophthalmic Physiol Opt,2012,32(1):3-16.

[17] Cho P, Cheung SW. Retardation of myopia in Orthokeratology (ROMIO) study: a 2-year randomized clinical trial[J]. Invest Ophthalmol Vis Sci,2012,53(11):7077-7085.

[18] Alharbi A, Swarbrick HA. The effects of overnight orthokeratology lens wear on corneal thickness[J]. Invest Ophthalmol Vis Sci,2003, 44(6):2518-2523.

[19] Sridharan R,Swarbrick H. Corneal response to short-term orthokeratology lens wear[J]. Optom Vis Sci,2003,80(3):200-206.

[20] Nichols JJ, Marsich MM, Nguyen M, et al. Overnight orthokeratology[J]. Optom Vis Sci,2000,77(5):252-259.

[21] Swarbrick HA. Orthokeratology review and update[J]. Clin Exp Optom,2006,89(3):124-143.

[22] Alharbi A, Swarbrick HA. The effects of overnight orthokeratology lens wear on corneal thickness[J]. Invest Ophthalmol Vis Sci,2003, 44(6):2518-2523.

[23] Sridharan R, Swarbrick H. Corneal response to short-term orthokeratology lens wear[J]. Optom Vis Sci,2003,80(3):200-206.

[24] Rah MJ, Jackson JM, Jones LA, et al. Overnight orthokeratology: preliminary results of the Lenses and Overnight Orthokeratology(LOOK) Study[J]. Optom Vis Sci,2002,79(9):598-605.

[25] Walline JJ, Rah MJ, Jones LA. The Children′s Overnight Orthokeratology Investigation (COOKI) pilot study[J]. Optom Vis Sci,2004,81(6):407-413.

[26] Sridharan R, Swarbrick H. Corneal response to short-term orthokeratology lens wear[J]. Optom Vis Sci,2003,80(3):200-206.

[27] Mika R, Morgan B, Cron M, et al. Safety and efficacy of overnight orthokeratology in myopic children[J]. Optometry,2007, 78(5):225-331.

[28] Cho P, Chui WS, Cheung SW. Reversibility of corneal pigmented arc associated with orthokeratology[J]. Optom Vis Sci,2003,80(12):791-795.

[29] 郭曦,杨丽娜,谢培英,等. 角膜塑形镜治疗青少年近视的远期效果[J]. 眼科,2012,21(6):371-374.

 

温馨提示:文章内容仅供参考不作为诊断或治疗标准,如需帮助请拨打梦戴维客服电话:400-025-2188 进行咨询。
声明:本站文章如未特殊声明皆为原创内容,转载请保留原文链接:http://www.myloveeye.com/mdw/174.html
角膜塑形镜咨询预约

客服中心

400-025-2188周一至周五8:30-17:30 免长途费
分享

热线电话:400-025-2188 在线咨询